Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Antileukemic bisabolane sesquiterpene isolated from natural sources

Jan. 10, 1997

Three new melanoma vaccines from Therion Biologics enter clinical testing

Jan. 9, 1997

QLT, AHP redefine Photofrin relationship

Jan. 9, 1997

Progress in Sugen's cancer development pipeline

Jan. 9, 1997

OXiGENE and Boston Medical Center announce collaboration

Jan. 9, 1997

Vion receives SBIR grant to develop ribonucleotide reductase inhibitor

Jan. 9, 1997

KGF receptor antagonists developed by U.S. researchers

Jan. 9, 1997

BCH-4556 slated to enter clinical testing

Jan. 8, 1997

Pharmacyclics completes phase I testing of Lu-Tex

Jan. 8, 1997

Draxis acquires Canadian rights to Mylan's paclitaxel formulation

Jan. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...